Exelixis, Inc. (EXEL)
41.07
-0.80
(-1.91%)
USD |
NASDAQ |
Dec 10, 16:00
41.07
0.00 (0.00%)
After-Hours: 05:15
Exelixis Market Cap: 11.01B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vanda Pharmaceuticals, Inc. | 398.90M |
| ADMA Biologics, Inc. | 4.755B |
| Aldeyra Therapeutics, Inc. | 288.18M |
| Merck & Co., Inc. | 242.30B |
| ACADIA Pharmaceuticals, Inc. | 4.536B |
Market Cap Related Metrics
| PE Ratio | 17.29 |
| PS Ratio | 5.136 |
| PEG Ratio | 0.3366 |
| Price to Book Value | 5.096 |
| Price to Free Cash Flow | 15.07 |
| Price | 41.07 |
| Earnings Yield | 5.78% |
| PEGY Ratio | 0.3366 |
| Operating PE Ratio | 14.33 |
| Normalized PE Ratio | 16.93 |